SG11201702260RA - Anti-cancer agent and cancer cell killing method - Google Patents
Anti-cancer agent and cancer cell killing methodInfo
- Publication number
- SG11201702260RA SG11201702260RA SG11201702260RA SG11201702260RA SG11201702260RA SG 11201702260R A SG11201702260R A SG 11201702260RA SG 11201702260R A SG11201702260R A SG 11201702260RA SG 11201702260R A SG11201702260R A SG 11201702260RA SG 11201702260R A SG11201702260R A SG 11201702260RA
- Authority
- SG
- Singapore
- Prior art keywords
- cancer
- cell killing
- killing method
- cancer cell
- agent
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 230000005880 cancer cell killing Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2014/075745 WO2016046989A1 (en) | 2014-09-26 | 2014-09-26 | Anti-cancer agent and method for killing cancer cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201702260RA true SG11201702260RA (en) | 2017-04-27 |
Family
ID=55580547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201702260RA SG11201702260RA (en) | 2014-09-26 | 2014-09-26 | Anti-cancer agent and cancer cell killing method |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10030039B2 (en) |
| EP (1) | EP3199152B1 (en) |
| JP (1) | JP6366725B2 (en) |
| SG (1) | SG11201702260RA (en) |
| WO (1) | WO2016046989A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11344740B2 (en) | 2019-02-07 | 2022-05-31 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
| US11027143B2 (en) | 2020-02-06 | 2021-06-08 | Vivek K. Sharma | System and methods for treating cancer cells with alternating polarity magnetic fields |
| CN113692302A (en) | 2019-02-07 | 2021-11-23 | V·K·沙玛 | System and method for treating cancer cells with alternating polarity magnetic fields |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE210967T1 (en) | 1993-01-29 | 2002-01-15 | Ferx Inc | MAGNETICALLY REACTING COMPOSITION AS A CARRIER FOR BIOLOGICALLY ACTIVE SUBSTANCES AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| AU2001253836A1 (en) * | 2000-04-26 | 2001-11-07 | Charlotte-Mecklenburg Hospital Authority D.B.A. Carolinas Medical Center | Method of treating cancer |
| US20040047852A1 (en) | 2001-03-02 | 2004-03-11 | Kennedy Thomas Preston | Method of treating cancer |
| US20090169484A1 (en) | 2007-12-28 | 2009-07-02 | Ihi Corporation | Iron-salen complex |
| RU2495045C2 (en) | 2008-11-20 | 2013-10-10 | АйЭйчАй КОРПОРЕЙШН | Complex compound of magnetisable metal and salen |
| WO2012106514A2 (en) * | 2011-02-03 | 2012-08-09 | Pop Test Cortisol Llc | System and method for diagnosis and treatment |
| JP2012167067A (en) * | 2011-02-15 | 2012-09-06 | Ihi Corp | Auto-magnetic metal salen complex compound |
| JP2014210742A (en) * | 2013-04-19 | 2014-11-13 | 株式会社Ihi | Persistent magnetic anticancer agent |
-
2014
- 2014-09-26 WO PCT/JP2014/075745 patent/WO2016046989A1/en active Application Filing
- 2014-09-26 JP JP2016549888A patent/JP6366725B2/en active Active
- 2014-09-26 SG SG11201702260RA patent/SG11201702260RA/en unknown
- 2014-09-26 EP EP14902283.2A patent/EP3199152B1/en active Active
-
2017
- 2017-03-24 US US15/468,462 patent/US10030039B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3199152A1 (en) | 2017-08-02 |
| US10030039B2 (en) | 2018-07-24 |
| JPWO2016046989A1 (en) | 2017-06-22 |
| EP3199152B1 (en) | 2021-05-26 |
| US20170240581A1 (en) | 2017-08-24 |
| EP3199152A4 (en) | 2018-04-11 |
| WO2016046989A1 (en) | 2016-03-31 |
| JP6366725B2 (en) | 2018-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251862A1 (en) | Methods and compositons for treating cancer | |
| IL252216B (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
| IL251630A0 (en) | Combination therapy for use in cancer therapy | |
| HUE054673T2 (en) | Methods and compositions for treating cancer | |
| GB201410270D0 (en) | Cell delivery system and method | |
| IL246607A0 (en) | Improved cell compositions and methods for cancer therapy | |
| EP3202909A4 (en) | Cancer specific-splicing ribozyme and use thereof | |
| SG11201704473WA (en) | New methods and uses | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| GB201416293D0 (en) | Methods and preparations | |
| SG11201702076WA (en) | Cancer evaluation method and cancer evaluation system | |
| IL250844A0 (en) | Therapeutic nanoparticles and related compositions, methods and systems | |
| SG11201702260RA (en) | Anti-cancer agent and cancer cell killing method | |
| GB201408091D0 (en) | Methods and uses | |
| HK1220676A1 (en) | Arrangement and method | |
| GB201516107D0 (en) | Complexes and methods for their preparation | |
| SG11201700191PA (en) | Microbiocides and uses thereof | |
| GB201416082D0 (en) | Method and uses | |
| GB201512334D0 (en) | Methods for selective killing of cancer cells | |
| GB201512216D0 (en) | Agents uses and methods | |
| GB201414904D0 (en) | Materials and methods for treating cancer | |
| PL3134581T3 (en) | Method and soil-stabilizing means | |
| GB201416073D0 (en) | Methods and uses | |
| GB201416086D0 (en) | Methods and uses | |
| GB201411111D0 (en) | bis-Pyridazine compounds and their use in treating cancer |